Drug
Codrituzumab
Codrituzumab: highest development phase Phase 1, developed by Chugai. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Chugai
Trials
| Drug | Phase | Indication |
|---|---|---|
| Codrituzumab NCT04928677 | Phase 1 | Primary Extra-cranial Solid Tumor |
Latest
No recent events.
Follow Codrituzumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.